Stockreport

Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine [Yahoo! Finance]

Evommune, Inc.  (EVMN) 
PDF PALO ALTO, Calif. & NEW YORK, April 06, 2026 BUSINESS WIRE )--Evommune, Inc. (NYSE: EVMN) ("Evommune" or the "Company"), a clinical-stage biotechnology company developi [Read more]